The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Share News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reckitt Benckiser Q1 sales jump, FY outlook lifted

Thu, 30th Apr 2020 07:36

(Sharecast News) - Consumer goods company Reckitt Benckiser lifted its full-year outlook on Thursday and reported a jump in first-quarter sales as demand for its products was boosted by the coronavirus pandemic.
In the three months to the end of March, total sales rose 12.3% to ?3.5bn, with like-for-like sales up 13.3%. Reckitt said growth was led by strong demand for many of its hygiene and health products, in particular Dettol, Lysol, Mucinex, Nurofen and VMS.

Reckitt said its 2020 performance is now expected to be ahead of original expectations, although the outlook for the balance of 2020 remains uncertain, with significant Covid-19 challenges across its markets.

Chief executive officer Laxman Narasimhan said: "We have seen strong consumer demand, particularly in March and April but the split between defensive buying and higher levels of underlying consumption is unclear.

"At this stage, it is uncertain how quickly this will change in the months ahead. Improved penetration and usage, particularly for products like Dettol and Lysol, may well sustain, although we will likely see some unwinding of 'pantry load' as we work our way through the crisis. The near-term operational challenges to meet additional demand and handle lockdown conditions, with the associated costs, are also likely to continue for some time."

At 1315 BST, the shares were up 4.3% at 6,674p.

Russ Mould, investment director at AJ Bell, said: "Reckitt Benckiser has demonstrated that not everyone is suffering equally in the coronavirus crisis. The consumer goods giant lifting outlook guidance feels like a dose of vitamins to a market facing a wave of profit warnings, dividend cuts and fundraisings.

"Reckitt's slant towards health and hygiene chimes perfectly with the need to look after ourselves and the reality that cleanliness is now less of an aspiration and more of a necessity. It is little surprise to see brands like Dettol, Lysol, Mucinex and Nurofen in demand.

"The business also seems to have passed the supply chain test in the face of exceptional demand that saw a substantial increase in sales in a very short period. The company is also doing its bit in the effort to tackle the pandemic by putting 1% of profit into a support fund, thereby ticking the good corporate citizen box.

"Although sales were lifted by stockpiling as the crisis took hold, it seems likely that some of the changes to consumer behaviour in the wake of the pandemic will be lasting. This could provide some extra pep to the recovery plan being delivered by CEO Laxman Narasimhan."

More News
24 Feb 2021 07:51

LONDON MARKET PRE-OPEN: Reckitt Boosted As Virus Drives Dettol Demand

LONDON MARKET PRE-OPEN: Reckitt Boosted As Virus Drives Dettol Demand

Read more
24 Feb 2021 07:47

UPDATE 3-Reckitt Benckiser predicts rosy outlook after record 2020

* Like-for-like sales grew by record 11.8% last year* Forecasts 2021 like-for-like sales up 0-2%* Announces sale of Scholl footcare business* Shares down 0.4% (Adds detail, mid-term outlook, updates shares)By Siddharth CavaleFeb 24 (Reuters) - Briti...

Read more
24 Feb 2021 07:47

UPDATE 2-Reckitt Benckiser predicts rosy outlook after record 2020

* Like-for-like sales grew by a record 11.8% last year* Forecasts 2021 like-for-like sales up 0-2%* Announces sale of Scholl footcare business* Shares up 1.7% (Adds detail, analyst, shares)By Siddharth CavaleFeb 24 (Reuters) - British consumer goods...

Read more
24 Feb 2021 07:02

Full-year sales hit record high at Reckitt Benckiser

(Sharecast News) - Reckitt Benckiser reported a surge in full-year revenues on Wednesday, after demand for cleaning and hygiene products spiked during the Covid-19 pandemic.

Read more
18 Feb 2021 07:37

UPDATE 2-Drugmaker Indivior prepares for pandemic hit to run into 2021

* Expects 2021 sales of up to $625 mln, assuming recovery in H2* In the worst case, forecasts 2021 sales of $565 mln* 2020 sales fall 18%, swings to operating loss on legal hit* Shares down 1.3% in early trade (Adds details on legal settlements, ne...

Read more
17 Feb 2021 15:57

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
15 Feb 2021 09:40

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

Read more
15 Feb 2021 08:13

LONDON BRIEFING: Pound Up As Vaccine Goal Reached But Pubs Suffering

LONDON BRIEFING: Pound Up As Vaccine Goal Reached But Pubs Suffering

Read more
8 Feb 2021 09:35

BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell

BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell

Read more
4 Feb 2021 11:53

UPDATE 3-Unilever's back to the future goals disappoint

* China, India boost performance in Q4* Sets long-term USG targets of 3-5% growth* Will invest up to 1 bln euros in R&D, e-commerce* Shares fall 4% (Adds details on strategic plan, compares outlooks with peers)By Siddharth CavaleFeb 4 (Reuters) - Un...

Read more
26 Jan 2021 17:16

LONDON MARKET CLOSE: Stocks Rise As IMF Lifts Global Growth Outlook

LONDON MARKET CLOSE: Stocks Rise As IMF Lifts Global Growth Outlook

Read more
26 Jan 2021 12:12

LONDON MARKET MIDDAY: FTSE 100 Charges Ahead Even As Rolls-Royce Drags

LONDON MARKET MIDDAY: FTSE 100 Charges Ahead Even As Rolls-Royce Drags

Read more
26 Jan 2021 09:29

UPDATE 2-London stocks climb as AstraZeneca, Indivior jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Indivior top mid-cap gainer* Rolls-Royce tumbles on lower engine travel expectations* UK's unemployment rate jumps to highest since 2016* F...

Read more
25 Jan 2021 18:05

UPDATE 2-Reckitt withdraws $1.4 bln claim against Indivior over U.S. opioid probe

* Companies settle indemnities over U.S. probe over Suboxone Film* Indivior to pay Reckitt $50 million over five-year period* Reckitt settled with United States in 2019, Indivior in 2020 (Writes through with details on settlement, background, shar...

Read more
25 Jan 2021 17:45

TOP NEWS: Indivior Reaches Settlement with Reckitt Benckiser

TOP NEWS: Indivior Reaches Settlement with Reckitt Benckiser

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.